Skip to main content

Cellectis, Stemgent Partner on Genome Engineering, mRNA Reprogramming

NEW YORK (GenomeWeb News) – Cellectis bioresearch, a subsidiary of Cellectis group, today said that it has partnered with Stemgent to provide research services that combine mRNA reprogramming and genome engineering.

The firms said that the combination of their technologies would "pave the way for clinically-relevant applications in regenerative medicine." Terms of the alliance were not disclosed.

Cellectis' expertise is in gene editing and genome engineering. The firm's Talen-based genome-engineering technology enables direct introduction of disease-specific genetic mutations that mimic disease and reporter genes with fluorescent/luminescent tags to evaluate drug candidate efficacy, specificity, and toxicity.

Stemgent has developed an mRNA reprogramming technology to derive non-integrating, clinically-relevant induced pluripotent stem cells for use in regenerative medicine, drug discovery, and basic research.

"The challenge researchers face is that current models to test drugs are often inadequate," Ian Ratcliffe, president and CEO of Cambirdge, Mass.-based Stemgent, said in a statement. "With this partnership and the combined technologies, we can introduce mutations into reprogrammed cells and differentiate them into downstream lineages. Researchers can utilize these cells to test how mutations, known and unknown, alter the biology of the cells upon exposure to drugs."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.